APA (7th ed.) Citation

AM, F., X, C., L, C., C, G., X, L., B, K., . . . NB, M. (2024). JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans. Scientific reports, 14(1), 17515. https://doi.org/10.1038/s41598-024-67371-5

Chicago Style (17th ed.) Citation

AM, Fourie, et al. "JNJ-77242113, a Highly Potent, Selective Peptide Targeting the IL-23 Receptor, Provides Robust IL-23 Pathway Inhibition upon Oral Dosing in Rats and Humans." Scientific Reports 14, no. 1 (2024): 17515. https://doi.org/10.1038/s41598-024-67371-5.

MLA (9th ed.) Citation

AM, Fourie, et al. "JNJ-77242113, a Highly Potent, Selective Peptide Targeting the IL-23 Receptor, Provides Robust IL-23 Pathway Inhibition upon Oral Dosing in Rats and Humans." Scientific Reports, vol. 14, no. 1, 2024, p. 17515, https://doi.org/10.1038/s41598-024-67371-5.